Humoral immune response to influenza vaccine in natalizumab-treated MS patients

Neurological Research

Volumn 34, Issue 7, 2012, Pages 730-733

  Vågberg, Mattias ^a   Kumlin, Urban ^a   Svenningsson, Anders ^a  

^a UMEÅ UNIVERSITY   (Sweden)

Author keywords

Autoimmune diseases; Influenza; Multiple sclerosis; Vaccination; Viral infections

Indexed keywords

IMMUNOGLOBULIN G; INFLUENZA VACCINE; NATALIZUMAB;

ADULT; ARTICLE; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; HUMAN; HUMORAL IMMUNITY; INFLUENZA VACCINATION; MALE; MULTIPLE SCLEROSIS;

ADULT; ANTIBODIES, MONOCLONAL, HUMANIZED; ANTIBODIES, VIRAL; COHORT STUDIES; FEMALE; HUMANS; IMMUNOGLOBULIN G; INFLUENZA VACCINES; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; YOUNG ADULT;

EID: 84865116357     PISSN: 01616412     EISSN: 17431328     Source Type: Journal    
DOI: 10.1179/1743132812Y.0000000059     Document Type: Article

References (10)

1. Polman CH, O'Connor PW, Havrdova E, Hutchinson M, Kappos L, Miller DH, et al. A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis. N Engl J Med. 2006;354(9):899-910.
2. Simmons DL. Anti-adhesion therapies. Curr Opin Pharmacol. 2005;5(4):398-404.
3. Holmen C, Piehl F, Hillert J, Fogdell-Hahn A, Lundkvist M, Karlberg E, et al. A Swedish national post-marketing surveillance study of natalizumab treatment in multiple sclerosis. Mult Scler. 2011;17(6):708-19.
4. Merelli E, Casoni F. Prognostic factors in multiple sclerosis: role of intercurrent infections and vaccinations against influenza and hepatitis B. Neurol Sci. 2000;21(4 Suppl 2):S853-6.
5. Salemi S, D'Amelio R. Are anti-infectious vaccinations safe and effective in patients with autoimmunity? Int Rev Immunol. 2010;29(3):270-314.
6. van den Berg R, van Hoogstraten I, van Agtmael M. Nonresponsiveness to hepatitis B vaccination in HIV seropositive patients; possible causes and solutions. AIDS Rev. 2009;11(3):157-64.
7. Michiels B, Govaerts F, Remmen R, Vermeire E, Coenen S. A systematic review of the evidence on the effectiveness and risks of inactivated influenza vaccines in different target groups. Vaccine. 2011;29(49):9159-70.
8. Sundstrom P, Juto P, Wadell G, Hallmans G, Svenningsson A, Nystrom L, et al. An altered immune response to Epstein-Barr virus in multiple sclerosis: a prospective study. Neurology. 2004;62(12):2277-82.
9. Goodwin K, Viboud C, Simonsen L. Antibody response to influenza vaccination in the elderly: a quantitative review. Vaccine. 2006;24(8):1159-69.
10. Cook IF. Sexual dimorphism of humoral immunity with human vaccines. Vaccine. 2008;26(29-30):3551-5.